|
2025 Journal Article The gut microbiome in B cell lymphomaVickers, Darcy, Martynchyk, Arina, Henden, Andrea, Smibert, Olivia C., Hawkes, Eliza A. and Chong, Geoff (2025). The gut microbiome in B cell lymphoma. Blood Reviews 101357, 101357. doi: 10.1016/j.blre.2025.101357 |
|
2025 Journal Article A simple scoring system for response and toxicity following lymphoma CAR-T: Results from the Australian CAR-T real-world consortiumDowling, Mark, Vanguru, Vinay, Boyle, Stephen, Cashion, Catelyn, Inam, Shafqat, Buss, Thomas, Jeffrey, Anthony, Scott, Hamish, MacDonald, Ross, Li, Jian, O'Leary, Nicole, Minson, Adrian, Brown, Christina, Anderson, Mary Ann, Sutrave, Gaurav, Belbachir, Safia, Butler, Jason, Curley, Cameron, Barraclough, Allison, Tam, Constantine, Henden, Andrea, Blyth, Emily, Ho, Phoebe Joy, Harrison, Simon and Dickinson, Michael (2025). A simple scoring system for response and toxicity following lymphoma CAR-T: Results from the Australian CAR-T real-world consortium. Blood, 146 (Supplement 1), 399-399. doi: 10.1182/blood-2025-399 |
|
2025 Journal Article Real-world outcomes with CAR T-cell therapy for secondary central nervous system lymphoma are similar between patients with active versus historical involvementCashion, Catelyn, Li, Jian, Farina, Sergio, Inam, Shafqat, Jeffrey, Anthony, MacDonald, Ross, Buss, Thomas, Vanguru, Vinay, Boyle, Stephen, Bishop, David, Brown, Christina, Barraclough, Allison, Tam, Constantine, Henden, Andrea, Dickinson, Michael, Blyth, Emily and Dowling, Mark (2025). Real-world outcomes with CAR T-cell therapy for secondary central nervous system lymphoma are similar between patients with active versus historical involvement. Blood, 146 (Supplement 1), 1936-1936. doi: 10.1182/blood-2025-1936 |
|
2025 Journal Article Multi-centre real-world outcome of patients with Richter transformation receiving CD19-directed commercial CAR T-cell therapy in AustraliaLi, Jian, Dowling, Mark, Jeffrey, Anthony, Farina, Sergio, Boyle, Stephen, MacDonald, Ross, Inam, Shafqat, Ma, Chun Kei Kris, Vanguru, Vinay, Perera, Nilu, Scott, Hamish, Dickinson, Michael, Seymour, John, Henden, Andrea, Blyth, Emily, Ho, Phoebe Joy, Tam, Constantine, Anderson, Mary Ann and Thompson, Philip (2025). Multi-centre real-world outcome of patients with Richter transformation receiving CD19-directed commercial CAR T-cell therapy in Australia. Blood, 146 (Supplement 1), 2779-2779. doi: 10.1182/blood-2025-2779 |
|
2025 Journal Article Cause and effect? A review of the impact of antibiotics on the gut microbiome in patients undergoing hematopoietic stem cell transplantationNakagaki, Midori, Hajkowicz, Krispin, Roberts, Jason A and Henden, Andrea S (2025). Cause and effect? A review of the impact of antibiotics on the gut microbiome in patients undergoing hematopoietic stem cell transplantation. Expert Review of Anti-infective Therapy, ahead-of-print (ahead-of-print), 1-14. doi: 10.1080/14787210.2025.2527970 |
|
2025 Journal Article p53 immunohistochemistry staining is a rapid screening method for TP53 mutation in myeloid malignancies suitable for integration into routine diagnostic laboratory practiceNelles, Ricky, Tallack, Michael R., Tate, Courtney, Hunt, Stewart, Aung, Hnin, Henden, Andrea, Jones, Lee and Seymour, Louise (2025). p53 immunohistochemistry staining is a rapid screening method for TP53 mutation in myeloid malignancies suitable for integration into routine diagnostic laboratory practice. Pathology, 57 (4), 489-494. doi: 10.1016/j.pathol.2024.11.011 |
|
2025 Journal Article Exploratory cost-utility analysis of a 37-gene panel versus usual care to guide therapy for patients with intermediate-risk myeloid malignanciesLindsay, Daniel, Henden, Andrea, Nelles, Ricky, Elliott, Thomas M. and Collins, Louisa G. (2025). Exploratory cost-utility analysis of a 37-gene panel versus usual care to guide therapy for patients with intermediate-risk myeloid malignancies. Applied Health Economics and Health Policy, 23 (3) 659595, 507-517. doi: 10.1007/s40258-024-00927-8 |
|
2025 Journal Article Allogeneic ‘off‐the‐shelf’ <scp>SARS</scp>‐<scp>C</scp>o<scp>V</scp>‐2‐specific adoptive T‐cell therapy for refractory viral infection and end organ diseaseHenden, Andrea S, Lineburg, Katie E, Panikkar, Archana, Mahajan, Arushi, Nelles, Ricky, Wright, Emma, Crooks, Pauline, Raju, Jyothy, Le Texier, Laetitia, Swaminathan, Srividhya, Beagley, Leone, Best, Shannon, Solomon, Matthew, Reddiex, Hilary, Kennedy, Glen, Tey, Siok‐Keen, Neller, Michelle A, Khanna, Rajiv and Smith, Corey (2025). Allogeneic ‘off‐the‐shelf’ SARS‐CoV‐2‐specific adoptive T‐cell therapy for refractory viral infection and end organ disease. Clinical & Translational Immunology, 14 (6) e70038, e70038. doi: 10.1002/cti2.70038 |
|
2024 Journal Article Low rates of complications and β-lactam resistance in viridans group streptococci bloodstream infection among cancer patients receiving chemotherapySheehy, Joshua, Scott, Ashleigh P., Henden, Andrea S., Kennedy, Glen, Redmond, Andrew M. and Stewart, Adam G. (2024). Low rates of complications and β-lactam resistance in viridans group streptococci bloodstream infection among cancer patients receiving chemotherapy. Journal of Antimicrobial Chemotherapy, 79 (8), 2040-2047. doi: 10.1093/jac/dkae209 |
|
2024 Journal Article Clinical grade multiparametric cell sorting and gene-marking of regulatory T cellsEkwe, Adaeze Precious, Au, Raymond, Zhang, Ping, McEnroe, Benjamin, Tan, Mei Ling, Saldan, Alda, Henden, Andrea S., Hutchins, Cheryl, Henderson, Ashleigh, Mudie, Kari, Kerr, Keri, Fuery, Madonna, Kennedy, Glen A., Hill, Geoffrey R. and Tey, Siok-Keen (2024). Clinical grade multiparametric cell sorting and gene-marking of regulatory T cells. Cytotherapy, 26 (7), 719-728. doi: 10.1016/j.jcyt.2024.02.023 |
|
2024 Journal Article Granulocyte transfusion supportive care for prolonged cytopenias post CD19 CAR T cell therapyPerera, Nilu, Baidya, Shoma, Weber, Nicholas, Mudie, Kari, Butler, Jason, Curley, Cameron, Henden, Andrea, Hunt, Stewart, Subramoniapillai, Elango, Tey, Siok‐Keen, Kennedy, Glen A. and Scott, Ashleigh P. (2024). Granulocyte transfusion supportive care for prolonged cytopenias post CD19 CAR T cell therapy. Transfusion, 64 (4), 762-765. doi: 10.1111/trf.17793 |
|
2024 Journal Article IL-6–mediated endothelial injury impairs antiviral humoral immunity after bone marrow transplantationZhang, Ping, Fleming, Peter, Andoniou, Christopher E., Waltner, Olivia G., Bhise, Shruti S., Martins, Jose Paulo, McEnroe, Benjamin A., Voigt, Valentina, Daly, Sheridan, Kuns, Rachel D., Ekwe, Adaeze P., Henden, Andrea S., Saldan, Alda, Olver, Stuart, Varelias, Antiopi, Smith, Corey, Schmidt, Christine R., Ensbey, Kathleen S., Legg, Samuel R.W., Sekiguchi, Tomoko, Minnie, Simone A., Gradwell, Mark, Wagenaar, Irma, Clouston, Andrew D., Koyama, Motoko, Furlan, Scott N., Kennedy, Glen A., Ward, E Sally, Degli-Esposti, Mariapia A. ... Tey, Siok-Keen (2024). IL-6–mediated endothelial injury impairs antiviral humoral immunity after bone marrow transplantation. Journal of Clinical Investigation, 134 (7) e174184, 1-15. doi: 10.1172/jci174184 |
|
2023 Journal Article ANZTCT consensus position statement on ruxolitinib in steroid‐refractory acute and chronic graft‐versus‐host diseaseHamad, Nada, Bilmon, Ian, Chee, Lynette, Henden, Andrea, Johnston, Anna, Purtill, Duncan, Bajel, Ashish, Tey, Siok‐Keen, Yeung, David, Cole, Theresa, Lewis, Clinton and Butler, Jason (2023). ANZTCT consensus position statement on ruxolitinib in steroid‐refractory acute and chronic graft‐versus‐host disease. Internal Medicine Journal, 53 (12), 2319-2329. doi: 10.1111/imj.16255 |
|
2023 Journal Article Quantifying skin cancer risk following allogeneic haematopoietic cell transplant in Queensland, AustraliaWong, Philip, Whiteman, David C., Olsen, Catherine M., Yuan, Yin, Butler, Jason, Curley, Cameron, Durrant, Simon, Henden, Andrea, Morton, James, Subramoniapillai, Elango, Stewart, Caroline, Tey, Siok-Keen, Kennedy, Glen A. and Scott, Ashleigh P. (2023). Quantifying skin cancer risk following allogeneic haematopoietic cell transplant in Queensland, Australia. Bone Marrow Transplantation, 59 (1) s41409-023-02138-6, 144-146. doi: 10.1038/s41409-023-02138-6 |
|
2023 Journal Article Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 yearsPeri, Anna Maria, Edwards, Felicity, Henden, Andrea, Harris, Patrick N. A., Chatfield, Mark D., Paterson, David L. and Laupland, Kevin B. (2023). Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 years. Clinical and Experimental Medicine, 23 (8), 4563-4573. doi: 10.1007/s10238-023-01206-x |
|
2023 Journal Article Fibre intake and supplementation during treatment for haematological malignancies: a scoping reviewAndersen, Sarah, Henden, Andrea, Staudacher, Heidi, Kennedy, Glen and Gavin, Nicole (2023). Fibre intake and supplementation during treatment for haematological malignancies: a scoping review. Journal of Human Nutrition and Dietetics, 36 (5), 1982-1991. doi: 10.1111/jhn.13209 |
|
2023 Journal Article PET assessment of acute gastrointestinal graft versus host diseaseScott, Ashleigh P., Henden, Andrea, Kennedy, Glen A. and Tey, Siok-Keen (2023). PET assessment of acute gastrointestinal graft versus host disease. Bone Marrow Transplantation, 58 (9), 973-979. doi: 10.1038/s41409-023-02038-9 |
|
2022 Journal Article High incidence of resistant breakthrough invasive fungal infections (IFD) in patients treated for acute gastrointestinal graft-versus-host disease (GI GVHD) following allogeneic haematopoietic cell transplantationYuan, Yin, Wong, Philip, Butler, Jason P., Henden, Andrea, Curley, Cameron, Durrant, Simon, Mediwake, Heshani, Morton, A. James, Stewart, Caroline, Subramoniapillai, Elango, Weber, Nicholas, Tey, Siok-Keen, Kennedy, Glen A. and Scott, Ashleigh P. (2022). High incidence of resistant breakthrough invasive fungal infections (IFD) in patients treated for acute gastrointestinal graft-versus-host disease (GI GVHD) following allogeneic haematopoietic cell transplantation. Bone Marrow Transplantation, 57 (11), 1-4. doi: 10.1038/s41409-022-01773-9 |
|
2021 Journal Article CMV exposure drives long-term CD57+ CD4 memory T-cell inflation following allogeneic stem cell transplantYeh, Albert C., Varelias, Antiopi, Reddy, Anupama, Barone, Sierra M., Olver, Stuart D., Chilson, Kate, Onstad, Lynn E., Ensbey, Kathleen S., Henden, Andrea S, Samson, Luke, Jaeger, Carla A, Bi, Timothy, Dahlman, Kimberly B., Kim, Tae Kon, Zhang, Ping, Degli-Esposti, Mariapia A., Newell, Evan W., Jagasia, Madan H., Irish, Jonathan M., Lee, Stephanie J. and Hill, Geoffrey R. (2021). CMV exposure drives long-term CD57+ CD4 memory T-cell inflation following allogeneic stem cell transplant. Blood, 138 (26), 2874-2885. doi: 10.1182/blood.2020009492 |
|
2021 Journal Article IFN-λ therapy prevents severe gastrointestinal graft-versus-host diseaseHenden, Andrea S., Koyama, Motoko, Robb, Renee J., Forero, Adriana, Kuns, Rachel D., Chang, Karshing, Ensbey, Kathleen S., Varelias, Antiopi, Kazakoff, Stephen H., Waddell, Nicole, Clouston, Andrew D., Giri, Rabina, Begun, Jakob, Blazar, Bruce R., Degli-Esposti, Mariapia A., Kotenko, Sergei V., Lane, Steven W., Bowerman, Kate L., Savan, Ram, Hugenholtz, Philip, Gartlan, Kate H. and Hill, Geoffrey R. (2021). IFN-λ therapy prevents severe gastrointestinal graft-versus-host disease. Blood, 138 (8), 722-737. doi: 10.1182/blood.2020006375 |
